Critical Review: KindlyMD (NAKA) versus Its Rivals

KindlyMD (NASDAQ:NAKA) is one of 340 publicly-traded companies in the “Financial Services” industry, but how does it weigh in compared to its competitors? We will compare KindlyMD to related businesses based on the strength of its dividends, valuation, profitability, risk, institutional ownership, analyst recommendations and earnings.

Institutional & Insider Ownership

43.2% of shares of all “Financial Services” companies are held by institutional investors. 24.1% of KindlyMD shares are held by insiders. Comparatively, 22.0% of shares of all “Financial Services” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Profitability

This table compares KindlyMD and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
KindlyMD	-1,067.93%	-63.45%	-41.04%
KindlyMD Competitors	-338.57%	-39.92%	-5.61%

Analyst Ratings

This is a summary of recent ratings and price targets for KindlyMD and its competitors, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KindlyMD	1	0	3	0	2.50
KindlyMD Competitors	1986	6961	11745	446	2.50

KindlyMD presently has a consensus target price of $20.00, suggesting a potential upside of 224.15%. As a group, “Financial Services” companies have a potential downside of 7.44%. Given KindlyMD’s higher possible upside, analysts plainly believe KindlyMD is more favorable than its competitors.

Risk & Volatility

KindlyMD has a beta of 16.03, indicating that its share price is 1,503% more volatile than the S&P 500. Comparatively, KindlyMD’s competitors have a beta of 2.51, indicating that their average share price is 151% more volatile than the S&P 500.

Valuation and Earnings

This table compares KindlyMD and its competitors revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
KindlyMD	$1.82 million	-$52.23 million	-0.17
KindlyMD Competitors	$6.46 billion	$1.09 billion	9.96

KindlyMD’s competitors have higher revenue and earnings than KindlyMD. KindlyMD is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summary

KindlyMD competitors beat KindlyMD on 9 of the 13 factors compared.

KindlyMD Company Profile

KindlyMD, Inc. is a healthcare company focused on providing integrated care for patients dealing with chronic pain, behavioral health conditions and substance-use disorders. The company emphasizes a patient-centered approach that combines medical treatment, behavioral health support and other services designed to address the underlying factors affecting a patient’s health and quality of life. KindlyMD’s services include chronic pain evaluation and management, medication-assisted treatment for opioid-use disorder, behavioral health care and related primary or supportive healthcare services.